CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $91,000 | +40.0% | 112,777 | +39.6% | 0.01% | 0.0% |
| Q4 2021 | $65,000 | +80.6% | 80,806 | +164.4% | 0.01% | +133.3% |
| Q3 2021 | $36,000 | -77.4% | 30,560 | -53.8% | 0.00% | -72.7% |
| Q1 2021 | $159,000 | +329.7% | 66,106 | +431.0% | 0.01% | +175.0% |
| Q4 2020 | $37,000 | -37.3% | 12,450 | -67.7% | 0.00% | -60.0% |
| Q3 2020 | $59,000 | +51.3% | 38,496 | +217.5% | 0.01% | +400.0% |
| Q4 2017 | $39,000 | -45.8% | 12,124 | -70.3% | 0.00% | -50.0% |
| Q3 2017 | $72,000 | – | 40,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields Capital Management, LLC | 2,188,547 | $1,751,000 | 0.22% |
| Wellington Shields & Co., LLC | 1,141,190 | $913,000 | 0.18% |
| Ikarian Capital, LLC | 1,223,067 | $978,000 | 0.15% |
| Ground Swell Capital, LLC | 18,638 | $15,000 | 0.09% |
| Anson Funds Management LP | 267,507 | $214,000 | 0.02% |
| Sterneck Capital Management, LLC | 40,000 | $32,000 | 0.02% |
| FEDERATED HERMES, INC. | 10,150,000 | $8,120,000 | 0.02% |
| Roundview Capital LLC | 122,453 | $98,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,677,146 | $1,342,000 | 0.01% |
| RBF Capital, LLC | 159,367 | $127,000 | 0.01% |